InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-10.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by NEUMANN CLARKE. Insider active across 3 companies, notably Progenity, INC.. In total, 18 disclosures have been recorded. History available since 15 May 2021. The latest transaction was filed on 15 August 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations18 total
26,629 shares@ US$0.6711.9% of flowCommon StockSEC:0000950170-24-098050:0
230,000 shares0Common StockSEC:0000950170-24-015859:0
36,183 shares@ US$3.1476.3% of flowCommon StockSEC:0000950170-23-043230:0
2,368 shares@ US$3.355.3% of flowCommon StockSEC:0000950170-23-022772:0
57,950 shares0Common StockSEC:0000899243-23-009036:0
84 shares@ US$3.460.2% of flowCommon StockSEC:0000899243-23-005464:0
44 sharesSeries X Preferred StockSEC:0000899243-23-000965:0
4,529 shares@ US$0.270.9% of flowCommon StockSEC:0000899243-22-036079:0
1,355 shares@ US$1.041.0% of flowCommon StockSEC:0000899243-22-028841:0
8,305 shares@ US$0.750.0000% mcap100.0% of flowCommon StockSEC:0000899243-22-018432:0
184,843 shares0Common StockSEC:0000899243-22-015060:0
1,716 shares@ US$1.9014.5% of flowCommon StockSEC:0000899243-22-006783:0
752 shares@ US$3.4711.5% of flowCommon StockSEC:0000899243-21-045047:0
752 shares@ US$3.4726.8% of flowCommon StockSEC:0000899243-21-045047
2,336 shares@ US$1.6616.5% of flowCommon StockSEC:0000899243-21-033256:0
2,336 shares@ US$1.6616.5% of flowCommon StockSEC:0000899243-21-033256
1,505 shares@ US$2.3614.8% of flowCommon StockSEC:0000899243-21-019674:0
1,505 shares@ US$2.3614.8% of flowCommon StockSEC:0000899243-21-019674
18 of 18 declarations
About NEUMANN CLARKE
Clarke Neumann is a director at Progenity, Inc. and Biora Therapeutics, Inc.
